# Treatment of Acute Myeloid Leukemia (AML) in Adults 50 to 70 Years, Study of Two Anthracyclines and the Interest of Maintenance Treatment With Interleukin 2

> **NCT00931138** · PHASE3 · COMPLETED · sponsor: **Acute Leukemia French Association** · enrollment: 420 (—)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** chemotherapy (Aracytine + Daunorubicin)
- **DRUG:** chemotherapy (Aracytine + Daunorubicin)
- **DRUG:** chemotherapy (Aracytine + Daunorubicin)

## Key facts

- **NCT ID:** NCT00931138
- **Lead sponsor:** Acute Leukemia French Association
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-12
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 420 (—)
- **Last updated:** 2009-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00931138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00931138, "Treatment of Acute Myeloid Leukemia (AML) in Adults 50 to 70 Years, Study of Two Anthracyclines and the Interest of Maintenance Treatment With Interleukin 2". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00931138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*